Curogen | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

168 results for “Curogen”

Trials

View all 50 →

Suturable DuraGen™ PMCF Study

260 participants · First posted Jun 11, 2021

Cutaneous Effects of Cryogen Spray Cooling

53 participants · First posted Dec 27, 2007

Duragen Versus Duraguard in Chiari Surgery

34 participants · First posted Aug 26, 2008

Drugs

View all 52 →

rAAV2-shmTOR-GFP (CuroGene Life Sciences/University of Ulsan)

rAAV2-sVEGFRv-1

Coprogen

C₃₅H₅₃FeN₆O₁₃

Organizations

View all 19 →

CURAGEN CORPORATION

United States

Urogen Pharma, Inc.

United States

UROGEN PHARMA LTD

Israel

News

View all 47 →

Curogen Appoints Industry Veteran Arvind Sood as Global COO to Lead US Expansion of Nanotechnology-Based Autoimmune Therapies

UroGen Pharma's UGN-102 Shows Promise in Bladder Cancer Treatment

UroGen Pharma Advances Bladder Cancer Pipeline with UGN-102 and UGN-103

Page 1 of 17